Stay updated with breaking news from Pathogenesis Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: Quidel Corporation Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation 02.11.2021 / 17:44 The issuer is solely responsible
Scientists approached by China Daily would not be drawn on the politicization of COVID-19 and insist any investigation into the origins of the virus that causes the disease should be based on science.
49% of patients treated with Opdivo plus Yervoy were alive at 6.5 years and 77% of these patients remained treatment-free Data to be featured in an oral presentation during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Bristol Myers Squibb (NYSE: BMY) today announced new six-and-a-half-year data from CheckMate -067, a randomized, double-blind, Phase 3 clinical trial, demonstrating durable improvement in survival with first-line Opdivo (nivolumab) plus Opdivo monotherapy, versus Yervoy alone, in patients with advanced melanoma. With a minimum follow-...
NEW YORK â A team of U.S. scientists, led by an Indian American researcher, has identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. According to Sumit K. Chanda, professor and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys Medical Discovery Institute, the scientists have gained new insights into how the virus exploits the human cells it invades. "We are still searching for its Achille's Heel so that we can develop optimal antivirals," Chanda said in a paper published in the journal Molecular Cell. Knowing which gen...
Print Scientists at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla have identified a set of human genes that fight SARS-CoV-2, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers’ understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body’s frontline virus fighters. “We wanted to gain a better understanding of the cellular response to SARS-CoV-2, including what drives a strong or weak response to infection...